iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogramโs collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a womanโs breast anatomy from the mammogram image.
์ข
๋ชฉ ์ฝ๋ ICAD
ํ์ฌ ์ด๋ฆICAD Inc
์์ฅ์ผDec 13, 1984
CEOMs. Dana R. Brown
์ง์ ์66
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃDec 13
์ฃผ์98 Spit Brook Rd Ste 100
๋์NASHUA
์ฆ๊ถ ๊ฑฐ๋์Euronext Paris
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ03062-5737
์ ํ16038825200
์น์ฌ์ดํธhttps://www.icadmed.com/
์ข
๋ชฉ ์ฝ๋ ICAD
์์ฅ์ผDec 13, 1984
CEOMs. Dana R. Brown
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์